Nucleic Acid Therapeutics Market - 2025-2032
Nucleic Acid Therapeutics Market reached US$ 5.64 billion in 2024 and is expected to reach US$ 14.42 billion by 2032, growing with a CAGR of 10.90% during the forecast period 2026-2032.
The Nucleic Acid Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Nucleic Acid Therapeutics Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Category
Both primary and secondary data sources have been used in the global Nucleic Acid Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The Nucleic Acid Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Nucleic Acid Therapeutics Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Category
- Antisense oligonucleotides (ASOs)*
- Small interfering RNA (siRNA)
- Messenger RNA (mRNA)
- Self-amplifying RNA (saRNA)
- Cancers*
- Viral Infections
- Genetic Disorders
- Others
- Hospitals*
- Academic & Research Institutes
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Nucleic Acid Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Category
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising demand for biopharmaceuticals
4.1.2. Restraints
4.1.2.1. High development costs
4.1.3. Opportunity
5. IMPACT ANALYSIS
6. INDUSTRY ANALYSIS
6.1. Porter’s Five Force Analysis
6.2. Supply Chain Analysis
6.3. Pricing Analysis
6.4. Patent Analysis
6.5. Regulatory Analysis
6.6. SWOT Analysis
6.7. Unmet Needs
7. BY CATEGORY
7.1. Introduction
7.1.1. Analysis and Y-o-Y Growth Analysis (%), By Category
7.1.2. Market Attractiveness Index, By Category
7.2. Antisense oligonucleotides (ASOs)*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Small interfering RNA (siRNA)
7.4. Messenger RNA (mRNA)
7.5. Self-amplifying RNA (saRNA)
8. BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Cancers*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Viral Infections
8.4. Genetic Disorders
8.5. Others
9. BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Academic & Research Institutes
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. MARKET SIZE ANALYSIS AND Y-O-Y GROWTH ANALYSIS (%), BY COUNTRY
11.1. U.S.
11.1.1. Canada
11.1.1.1. Mexico
11.2. Europe
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.6.1. Germany
11.2.6.2. U.K.
11.2.6.3. France
11.2.6.4. Spain
11.2.6.5. Italy
11.2.6.6. Rest of Europe
11.3. South America
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.6.1. Brazil
11.3.6.2. Argentina
11.3.6.3. Rest of South America
11.4. Asia-Pacific
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.6.1. China
11.4.6.2. India
11.4.6.3. Japan
11.4.6.4. South Korea
11.4.6.5. Rest of Asia-Pacific
11.5. Middle East and Africa
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. COMPETITIVE LANDSCAPE
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. COMPANY PROFILES
13.1. Ionis Pharmaceuticals*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Alnylam Pharmaceuticals, Inc.
13.3. Gilead Sciences, Inc.
13.4. Sarepta Therapeutics, Inc.
13.5. Creative Biolabs
13.6. GSK plc
13.7. Novartis AG
13.8. BioNTech SE.
13.9. Silence Therapeutics
13.10. AstraZeneca (LIST NOT EXHAUSTIVE)
14. APPENDIX
14.1. About Us and Services
14.2. Contact Us
Suggestions for Related Report
• Nucleic Acid Testing Market (https://www.datamintelligence.com/research-report/nucleic-acid-testing-market)
• Nucleic Acid Isolation and Purification Market (https://www.datamintelligence.com/research-report/nucleic-acid-isolation-and-purification-market)
For more pharmaceuticals-related reports, please click here (https://www.datamintelligence.com/industry-verticals/pharmaceuticals)
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Category
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising demand for biopharmaceuticals
4.1.2. Restraints
4.1.2.1. High development costs
4.1.3. Opportunity
5. IMPACT ANALYSIS
6. INDUSTRY ANALYSIS
6.1. Porter’s Five Force Analysis
6.2. Supply Chain Analysis
6.3. Pricing Analysis
6.4. Patent Analysis
6.5. Regulatory Analysis
6.6. SWOT Analysis
6.7. Unmet Needs
7. BY CATEGORY
7.1. Introduction
7.1.1. Analysis and Y-o-Y Growth Analysis (%), By Category
7.1.2. Market Attractiveness Index, By Category
7.2. Antisense oligonucleotides (ASOs)*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Small interfering RNA (siRNA)
7.4. Messenger RNA (mRNA)
7.5. Self-amplifying RNA (saRNA)
8. BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Cancers*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Viral Infections
8.4. Genetic Disorders
8.5. Others
9. BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Academic & Research Institutes
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. MARKET SIZE ANALYSIS AND Y-O-Y GROWTH ANALYSIS (%), BY COUNTRY
11.1. U.S.
11.1.1. Canada
11.1.1.1. Mexico
11.2. Europe
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.6.1. Germany
11.2.6.2. U.K.
11.2.6.3. France
11.2.6.4. Spain
11.2.6.5. Italy
11.2.6.6. Rest of Europe
11.3. South America
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.6.1. Brazil
11.3.6.2. Argentina
11.3.6.3. Rest of South America
11.4. Asia-Pacific
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.6.1. China
11.4.6.2. India
11.4.6.3. Japan
11.4.6.4. South Korea
11.4.6.5. Rest of Asia-Pacific
11.5. Middle East and Africa
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. COMPETITIVE LANDSCAPE
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. COMPANY PROFILES
13.1. Ionis Pharmaceuticals*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Alnylam Pharmaceuticals, Inc.
13.3. Gilead Sciences, Inc.
13.4. Sarepta Therapeutics, Inc.
13.5. Creative Biolabs
13.6. GSK plc
13.7. Novartis AG
13.8. BioNTech SE.
13.9. Silence Therapeutics
13.10. AstraZeneca (LIST NOT EXHAUSTIVE)
14. APPENDIX
14.1. About Us and Services
14.2. Contact Us
Suggestions for Related Report
• Nucleic Acid Testing Market (https://www.datamintelligence.com/research-report/nucleic-acid-testing-market)
• Nucleic Acid Isolation and Purification Market (https://www.datamintelligence.com/research-report/nucleic-acid-isolation-and-purification-market)
For more pharmaceuticals-related reports, please click here (https://www.datamintelligence.com/industry-verticals/pharmaceuticals)
